EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway

Jie Zhou iD, Shengmeng Peng, Huiyang Fan, Jin Li, Zean Li, Ganping Wang, Lexiang Zeng, Zhenghui Guo, Yiming Lai, Hai Huang

Cancer Medicine · 2023-06 · 12 (12) · 13471-13485

DOI: 10.1002/cam4.5998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 29.04.2023. Verfasst von Jie Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The mechanism involved in prostate cancer (PCa) metastasis is still poorly understood, and several oncogenes are known to regulate this process. However, the role of spalt‐like transcription factor 4 (SALL4) in PCa metastasis remains unclear.

Methods

We performed RNA‐sequencing to compare the mRNA expression profiles of seven localized PCa tissues and six metastatic PCa tissues. SALL4 was then identified and compared in the localized PCa and metastatic PCa. Immunohistochemical studies, qRT‐PCR, and Western blot were performed to analyze the expression of SALL4 in PCa patients and cell lines. SALL4 expression and its relevance to clinical traits and prognosis were further explored in the TCGA database and in our 68 clinical samples. Subsequently, we knocked down SALL4 in DU145 and PC3 cells and performed a series of functional assays to explore the effect of SALL4 on PCa progression. Finally, protein levels of SALL4 and core components of the MAPK pathway were measured by Western blot, and cells were treated with PD0325901 to observe proliferation and metastasis.

Results

Significantly higher expression of SALL4 was found in metastatic PCa than in localized PCa. In addition, high SALL4 expression was significantly associated with high pathological T stage, N stage, Gleason score, and poor disease‐free survival in TCGA database and in our clinical samples. Functional studies indicated that knockdown of SALL4 in DU145 and PC3 inhibited proliferation, migration, and angiogenesis. Furthermore, the ERK and P38 protein phosphorylation significantly reduced after knockdown of SALL4 in DU145 and PC3, indicating the inactivation of the MAPK signaling pathway. Finally, the proliferation and migration ability of DU145 and PC3 cells were significantly decreased after PD0325901 treatment.

Conclusions

SALL4 predicts unfavorable outcome and is closely associated with PCa progression, suggesting that SALL4 may be a promising prognostic marker and potential therapeutic target for PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansCell Line, TumorCell ProliferationPrognosisCell MovementGene Expression Regulation, NeoplasticTranscription FactorsBenzamidesDiphenylamine

Stichwörter der Autor:innen

MAPK pathwaySALL4metastasisprostate cancer

Substanzen

Transcription FactorsmirdametinibBenzamidesDiphenylamineSALL4 protein, human

Autor:innen und Institutionen

  • Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, China.
  • Department of Reproductive Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.

ORCID-Profile: Jie Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, J., Peng, S., Fan, H., Li, J., Li, Z., Wang, G., Zeng, L., Guo, Z., Lai, Y., & Huang, H. (2023). SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway. Cancer Medicine, 12(12), 13471-13485. https://doi.org/10.1002/cam4.5998

Vancouver

Zhou J, Peng S, Fan H, Li J, Li Z, Wang G, et al. SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway. Cancer Medicine. 2023;12(12):13471-13485. doi:10.1002/cam4.5998

BibTeX
@article{Zhou2023,
  author = {Zhou, Jie and Peng, Shengmeng and Fan, Huiyang and Li, Jin and Li, Zean and Wang, Ganping and Zeng, Lexiang and Guo, Zhenghui and Lai, Yiming and Huang, Hai},
  title = {SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {13471--13485},
  doi = {10.1002/cam4.5998}
}
Kostenlos starten →